6C7-27337-27892
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 467 / IN
- Registered
- 2021-12-19
- Relationship
- Child or adolescent in my care
- Guardian
- SF2-24005-71114
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-16
Dose 1 — Pfizer-BioNTech
-
2021-12-19
Registered in v-safe
-
2021-12-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-20
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Slightly runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
-
2021-12-22
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Discharge, Respiratory tract congestion — Feeling: GoodFree text: Congestion and drainageMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
- 2021-12-30
-
2022-01-06
Dose 2 — Pfizer-BioNTech
- 2022-01-06
- 2022-01-20
- 2022-01-29
- 2022-02-03
- 2022-02-10
- 2022-02-17
- 2022-04-07
- 2022-07-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-16 | Pfizer-BioNTech | No |
| 2 | 2022-01-06 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Slightly runny nose
Systemic reaction (other): Congestion and drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Discharge | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release